Related Experiment Video
Updated: Jun 11, 2026
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Experimental therapies and clinical trials in bone sarcoma
1Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan 48109-5843, USA. rashmim@med.umich.edu
Summary
This article reviews clinical trials for osteosarcoma, Ewing sarcoma family tumors, and chondrosarcoma, the most common bone cancers. It highlights advancements and ongoing research for these rare malignancies.
Area of Science:
- Oncology
- Orthopedic Oncology
- Clinical Trials
Background:
- Bone sarcomas are rare cancers, comprising 0.2% of adult and 6% of pediatric malignancies.
- Limited resources often hinder research into these challenging diseases.
- Despite rarity, significant treatment advancements have been achieved.
Purpose of the Study:
- To discuss recently completed and currently enrolling clinical trials for bone sarcomas.
- To provide an overview of the therapeutic landscape for common bone sarcomas.
- To inform physicians and patients about ongoing research efforts.
Main Methods:
- Review of completed clinical trials.
- Analysis of currently enrolling clinical trials.
- Focus on osteosarcoma, Ewing sarcoma family tumors, and chondrosarcoma.
Main Results:
- Identification of key completed trials.
- Summary of active research protocols.
- Highlighting progress in treatment strategies.
Conclusions:
- Ongoing clinical trials are crucial for advancing bone sarcoma treatment.
- Continued research is essential to overcome challenges posed by these rare cancers.
- The discussed trials offer hope for improved patient outcomes.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...